Using Patient Feedback to Optimize the Design of a Certolizumab Pegol Electromechanical Self-Injection Device: Insights from Human Factors Studies

INTRODUCTION: We incorporated patient feedback from human factors studies (HFS) in the patient-centric design and validation of ava(®), an electromechanical device (e-Device) for self-injecting the anti-tumor necrosis factor certolizumab pegol (CZP). METHODS: Healthcare professionals, caregivers, he...

Descripción completa

Detalles Bibliográficos
Autores principales: Domańska, Barbara, Stumpp, Oliver, Poon, Steven, Oray, Serkan, Mountian, Irina, Pichon, Clovis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778191/
https://www.ncbi.nlm.nih.gov/pubmed/29222625
http://dx.doi.org/10.1007/s12325-017-0645-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778191/
https://www.ncbi.nlm.nih.gov/pubmed/29222625
http://dx.doi.org/10.1007/s12325-017-0645-1

Ejemplares similares